Lapiz, Gemilyn B.

HRN: 21-51-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2022
CEFTRIAXONE 1G (VIAL)
06/28/2022
06/28/2022
IVT
2g
On Call To OR
Pre-op Prophylaxis For Pelvic Lap
Waiting Final Action 
06/28/2022
CEFTRIAXONE 1G (VIAL)
06/28/2022
06/30/2022
IV
2gm
Q12 X 2 More Doses
Post OP (Pelvic Laparotomy) Prophylaxis
Waiting Final Action 
06/29/2022
CEFUROXIME 500MG (TAB)
06/29/2022
07/06/2022
PO
500mg
BID X 7 Days
Wbc: 17.8; Post-op
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: